Valuation: PharmaEssentia Corporation

Market Cap 52TCr 1.61TCr 1.41TCr 1.3TCr 1.19TCr 2.26TCr 1,55100Cr 2.3TCr 16TCr 6.08TCr 76TCr 6.04TCr 5.91TCr 2,61300Cr P/E 2026 *
48.4x
P/E 2027 * 35.2x
Enterprise Value 49TCr 1.53TCr 1.33TCr 1.23TCr 1.13TCr 2.14TCr 1,47200Cr 2.19TCr 15TCr 5.77TCr 72TCr 5.74TCr 5.61TCr 2,48000Cr EV / Sales 2026 *
19.7x
EV / Sales 2027 * 14x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-4.55%
1 week-8.65%
Current month+4.31%
1 month+46.82%
3 months+115.03%
6 months+161.74%
Current year+197.38%
1 week 1,165
Extreme 1165
1,365
1 month 887.06
Extreme 887.0636
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-8.65%+194.32%+349.58% 1.69TCr
-3.42%+10.05%+58.59%+87.70% 5.78TCr
-0.05%-6.20%+55.97%+124.61% 5.37TCr
-2.14%-7.78%+4.46%+421.65% 2.38TCr
-0.47%-2.11%-17.25%-15.41% 2.33TCr
-0.56%+10.26%+44.03%-3.86% 2.07TCr
-0.29%-0.08%+38.91%-27.98% 1.78TCr
-2.61%+8.99%+46.11%+691.67% 1.64TCr
+0.23%-0.77%+26.37%+187.16% 1.4TCr
-0.86%-3.51%+75.33%+141.63% 1.27TCr
Average -1.47%+0.68%+52.68%+195.67% 2.57TCr
Weighted average by Cap. -1.58%+0.04%+50.83%+165.34%

Financials

2026 *2027 *
Net sales 2.51TCr 78Cr 68Cr 63Cr 58Cr 108.96Cr 7.48TCr 111.13Cr 748.45Cr 293.35Cr 3.66TCr 291.68Cr 285.32Cr 13TCr 3.46TCr 107.13Cr 94Cr 86Cr 79Cr 150.25Cr 10TCr 153.23Cr 1.03TCr 404.49Cr 5.04TCr 402.19Cr 393.43Cr 17TCr
Net income 1.09TCr 34Cr 29Cr 27Cr 25Cr 47Cr 3.24TCr 48Cr 324.08Cr 127.02Cr 1.58TCr 126.29Cr 123.54Cr 5.46TCr 1.5TCr 46Cr 41Cr 37Cr 34Cr 65Cr 4.47TCr 66Cr 447Cr 175.2Cr 2.18TCr 174.2Cr 170.4Cr 7.53TCr
Net Debt -2.65TCr -82Cr -72Cr -66Cr -61Cr -115.29Cr -7.92TCr -117.58Cr -791.93Cr -310.39Cr -3.87TCr -308.62Cr -301.9Cr -13TCr -3.47TCr -107.63Cr -94Cr -87Cr -80Cr -150.95Cr -10TCr -153.95Cr -1.04TCr -406.39Cr -5.07TCr -404.07Cr -395.27Cr -17TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
16/26/16 NT$1,260.00 -4.55% 44,20,281
15/26/15 NT$1,320.00 +10.00% 21,57,754
14/26/14 NT$1,200.00 -4.00% 40,37,292
13/26/13 NT$1,250.00 -2.72% 33,73,173
09/26/09 NT$1,285.00 -6.84% 67,11,957
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,260.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-16.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock